<DOC>
	<DOCNO>NCT00258908</DOCNO>
	<brief_summary>To assess immunogenicity profile ADACEL™ , Tetanus Diphtheria Toxoids Adsorbed combine Component Pertussis Vaccine ( TdcP Vaccine ) one month administration . To describe safety profile ADACEL™ ( TdcP Vaccine ) give fifth dose .</brief_summary>
	<brief_title>Immunogenicity Safety ADACEL™ Fifth Dose Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 6 8 year day inclusion Informed consent form ( ICF ) sign parent ( ) /legal representative Able attend schedule visit comply trial procedure Written documentation complete primary series fourth dose Diphtheria , Tetanus toxoids whole cell Pertussis vaccine ( DTP ) Parent ( ) /legal representative present fully complete preinclusion medical questionnaire Participation another clinical trial 4 week precede trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , long term systemic corticosteroid therapy Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance specific focus subject , previous administration DTP diphtheria tetanus toxoid acellular pertussis ( DTaP ) vaccine , one follow adverse event 1. encephalopathy attributable another identifiable cause within 7 day administration previous dose 2. temperature &gt; 40.5 °C within 48 hour due another identifiable cause 3. collapse shocklike state ( hypotonichyporesponsive episode ) within 48 hour 4. persistent , inconsolable cry last &gt; 3 hour , occur within 48 hour 5. seizure without fever occur within 3 day Chronic illness stage could interfere trial conduct completion . Blood bloodderived product receive past 3 month Any vaccination 4 week precede trial vaccination ( except Oral Poliomyelitis Vaccine [ OPV ] ) Any vaccination plan present trial period ( except OPV ) History diphtheria and/or tetanus and/or pertussis infection ( confirm either clinically , serologically microbiologically ) Previous fifth vaccination diphtheria and/or tetanus and/or pertussis infection trial vaccine another vaccine Clinical serological evidence systemic illness include Hepatitis B , C Human Immunodeficiency Virus ( HIV ) Thrombocytopenia bleed disorder contraindicate intramuscular vaccination History of/current seizure Febrile illness ( axillary temperature ≥ 37.4 °C ) acute illness day inclusion</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ADACEL™</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Diphteria</keyword>
	<keyword>Acellular pertussis</keyword>
</DOC>